These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30153063)

  • 1. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.
    Kupreeva M; Diane A; Lehner R; Watts R; Ghosh M; Proctor S; Vine D
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E16-E33. PubMed ID: 30153063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.
    Vine DF; Wang Y; Jetha MM; Ball GD; Proctor SD
    J Clin Endocrinol Metab; 2017 Mar; 102(3):970-982. PubMed ID: 27997268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
    He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
    Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
    Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
    J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
    Xing C; Lv B; Zhao H; Wang D; Li X; He B
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens exacerbate hepatic triglyceride accumulation in rats with polycystic ovary syndrome by downregulating MTTP expression.
    Wang D; Zhao H; Xing C; Lv B; Wang X; He B
    Endocrine; 2024 May; 84(2):735-744. PubMed ID: 37950821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
    Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X
    Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome.
    Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K
    Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
    Hurliman A; Keller Brown J; Maille N; Mandala M; Casson P; Osol G
    Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone can improve liver sex hormone-binding globulin levels and lipid metabolism in polycystic ovary syndrome by regulating hepatocyte nuclear factor-4α.
    Zhao H; Wang D; Xing C; Lv B; Wang X; He B
    J Steroid Biochem Mol Biol; 2023 May; 229():106265. PubMed ID: 36737028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
    Shi D; Dyck MK; Uwiera RR; Russell JC; Proctor SD; Vine DF
    Endocrinology; 2009 Sep; 150(9):4425-36. PubMed ID: 19470707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
    Sahin I; Serter R; Karakurt F; Demirbas B; Culha C; Taskapan C; Kosar F; Aral Y
    Gynecol Endocrinol; 2004 Sep; 19(3):115-24. PubMed ID: 15697072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
    Cardoso RC; Burns A; Moeller J; Skinner DC; Padmanabhan V
    Endocrinology; 2016 Dec; 157(12):4641-4653. PubMed ID: 27792406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
    Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
    Ryan GE; Malik S; Mellon PL
    Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.